ProMIS Neurosciences

PMNNasdaq Canada Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$31.746 M

$3.54 +0.57%

Close of 6 Nov 2026

As of 6 Nov 2026, ProMIS Neurosciences (PMN) has a market capitalization of $31.7M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$39.7M

Loss-making

Shares outstanding

8,967,693

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#359ScynexisSCYX$33.1M
#360NanoviricidesNNVC$32.9M
#361ProMIS NeurosciencesPMN$31.7M
#362Rockwell MedicalRMTI$30.8M
#363Lite StrategyLITS$30.0M

Insiders buying

All insider buying →

One open-market purchase by officers and directors of ProMIS Neurosciences, worth $30.3K. Grants and option exercises are excluded.

Johanne KaplanChief Development Officer$30.3K
2,280 shares at $13.30 on 5 Aug 2026 · filed 7 Aug 2026

What if ProMIS Neurosciences were worth as much as…

Open the what-if tool →

Gold $28.2T

$3,148,733

Per share 889,473× higher

Bitcoin $1.53T

$170,372.48

Per share 48,128× higher

Apple $5.02T

$559,316.94

Per share 157,999× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for ProMIS Neurosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.